✦ LIBER ✦

512 EFFICACY AND SAFETY OF TELBIVUDINE USE IN HIGHLY VIREMIC MOTHERS WITH HBEAG+ CHRONIC HEPATITIS B (CHB) IN CLINICAL PRACTICE

✍ Scribed by G. Han; H. Jiang; W. Zhao; C. Ge; C. Xu

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

513 COMPARISON OF TELBIVUDINE USE IN THE

✍ G. Han; W. Zhao; C. Ge; C. Xu; H. Jiang 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 182 KB

539 2-YEAR RESULTS OF TELBIVUDINE (LDT)

✍ T. Piratvisuth; P. Komolmit; T. Tanwandee; W. Sukeepaisarnjaroen; H.L. Chan; M.G 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 62 KB

496 Efficacy and safety of 2 years adefo

✍ M.D. Zeng; Y.M. Mao; G.B. Yao; H. Wang; J.L. Hou; Y.Z. Wang; J.S. Dixon; K.E. Ba 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 116 KB

Incidence and Predictors of Hepatitis B

✍ Lin, Brian ;Ha, Nghiem B. ;Liu, Anne ;Trinh, Huy N. ;Nguyen, Huy A. ;Nguyen, Kha 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 570 KB

493 Phase III comparison of telbivudine

✍ E. Gane; C.L. Lai; Y.E. Liaw; S. Thongsawat; Y. Wang; Y. Cheng; J. Heathcote; J. 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 244 KB

Incidence of Hepatitis B E Antigen (HBeA

✍ Liu, Anne ;Ha, Nghiem B. ;Lin, Brian ;Yip, Benjamin ;Trinh, Huy N. ;Nguyen, Huy 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 806 KB